Carcinoma, Intraductal, Noninfiltrating clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)
Sorry, in progress, not accepting new patients
This is a study to investigate the change in the immune microenvironment of high risk ductal carcinoma in situ (DCIS) after short term exposure to immunotherapy.
at UCSF
Last updated: